Brain & Neurology
-
Junk’ DNA provides information about neurological disorders
New insights into non-coding DNA could help to unlock new treatments for neurological disorders, scientists believe. Read more
-
Backing for wearable devices for Parkinson’s patients
Five “promising” wearable technologies that could help to improve symptoms and quality of life for Parkinson’s disease patients, according to proposed new guidance for the UK NHS published today. Read more
-
Breakthrough in motor neurone disease treatment
A new drug for motor neurone disease has yielded “notable” results in a phase 3 trial, British researchers have reported. Read more
-
Neurological complications linked to monkeypox
Monkeypox has been linked to rare cases of neurological complications, including encephalitis and confusion, according to a new review of evidence. Read more
-
Multiple risks linked to obstructive sleep apnoea
People with obstructive sleep apnoea (OSA) have a higher risk of developing cancer, an increase in blood clots and experience a decline in mental processing powers, a European conference has heard. Read more
-
Ecstasy and psychotherapy combined for PTSD
Magic mushrooms and ecstasy show the most promise when it comes to helping people with post-traumatic stress disorder, a new review has suggested. Read more
-
Chickenpox virus has role in Alzheimer’s Disease
The varicella zoster virus (VZV), which causes chickenpox and shingles, may play a role in the development of Alzheimer’s disease (AD), British researchers report today. Read more
-
Noradrenergic drugs appear effective for Alzheimer’s
Noradrenergic drugs, often prescribed for hypotension and attention deficit hyperactivity disorder, may be an effective treatment for Alzheimer’s disease, researchers report today. Read more
-
Brain surgery benefits intracranial pressure
Craniectomy for intracranial hypertension offers significant benefit, according to new guidance, triggered by British research. Read more
-
Increased neurodegenerative disorder risk after COVID-19
People who contract COVID-19 have an increased risk of neurodegenerative disorders compared to individuals who have not had the virus, a European conference has heard. Read more